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Our understanding of the functions that non-coding RNAs play in shaping the immune response
is still in its infancy. The breakthroughs in deep sequencing technology have provided us with an
unprecedented view of the human genome. The deeper we sequence the more non-coding genes
we identify, while the number of protein coding genes remains constant. GENCODE represents
the gene set of the ENCODE project and there are currently 15,931 long non-coding RNA (lncRNA)
genes, 9,882 small non-coding RNAgenes, and 14,477 Pseudogenes cataloged inGENCODEversion
231. The contribution of each of these genes to biological processes still remains to be determined.
In this research topic, we explore recent data surrounding the functions for microRNA (miRNA) as
well as lncRNA within Innate Immunity.
Innate immune responses to infection involve the production of pro-inflammatory cytokines
such as IL-6 and TNFα in addition to the Type I Interferons (IFNs) that play critical roles in
anti-viral immunity. In recent years, there have been huge strides made in understanding the
contributions of small RNAs such as miRNA to the Innate Immune processes. More recently, our
attention has also been drawn to the growing catalog of lncRNAs. miRNAs are ~22 nt in length
are function through post-transcriptional regulation of protein coding genes through regulating
translation and RNA stability. LncRNA are transcripts greater than 200 nt in length that do not
encode for protein. Both miRNAs and lncRNAs are RNA pol II transcripts, that are capped and
many are polyadenylated; however, there is also evidence that both lncRNA and miRNA can be
transcribed by RNA polymerase III (1, 2). The vast functions for miRNA and lncRNA within the
innate immune responses are thoroughly reviewed in this research topic by Foster et al., Stachurska
et al., and Imamura and Akimitsu (3–5).
NON-CODING RNA AND INTERFERON
It is critical that innate immune signaling remains transient as any perturbations to these com-
plex pathways can have devastating consequences for the host. For this reason, there are many
positive and negative feedback mechanisms in place to keep the pathways in check. miRNAs
can act as fine tuners of immune signaling. Type I IFNs are critical for protection against
viral infection and more than 30 miRNAs have been shown to be differentially regulated by
IFN stimulation with many of these targeting IFN-β acting as negative feedback regulators
(3, 6). There are three original research articles within this research topic that center on IFN
inducible lncRNAs and like miRNAs they appear to form critical functions as key regulators
of the anti-viral immune pathways (7–9). Interestingly, two independent research articles iden-
tify the same IFNα inducible lncRNA BST2 IFN-stimulated positive regulator (BISPR) (8, 9).
A bi-directional promoter of the protein-coding gene BST2 transcribes BISPR that then acts
as a positive regulator for BST2 expression. siRNA-mediated knockdown of BISPR had a dra-
matic impact on BST2 protein expression levels. The original articles in this series identify
1http://www.gencodegenes.org/stats/current.html
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a large number of lncRNAs whose functions within anti-viral
immunity remain to be determined.
Throughout this research topic, we return to the idea of reg-
ulatory loops, which includes miR21, which is capable of nega-
tively regulating the pathway that is responsible for its induction
(10). miR21 serves many functions within the innate immune
response and these are reviewed in depth in this research topic
(10). miRNAs and lncRNAs form their own complex regulatory
loopswithmany lncRNAs being targets bymiRNAs and vice versa.
Circular RNA is a specialized type of lncRNA that can act as
miRNA sponges increasing the complexity of these regulatory
loops further (11). No functions for circRNA in innate immune
responses have been identified to date.
NON-CODING RNA IN DISEASE AND
DEVELOPMENT
A large number of non-coding RNAs are dysregulated in complex
inflammatory diseases. The exact extent to which differentially
regulated miRNA and lncRNA contribute to disease patholo-
gies are still under intense investigation and reviewed here by
Stachurska et al. (4). miR146a is a key regulator of the inflam-
matory response. Reduced levels of miR146 are associated with
Systemic Lupus Erthyromatosis. The miR146 knockout mice dis-
play an autoimmune phenotype as well as developing tumors with
age. The extended functions of miR146 in innate immunity are
reviewed by Saba et al. (12).
miRNAs have been shown to act as key regulators of innate
immune cell development. MiR-223 is involved in granulocyte
production, themiR125 family,miR142,miR155,mir342,mir338,
and miR145 all play roles in macrophage differentiation (4). To
date, only two lncRNAs have been shown to be involved in innate
immune cell differentiation. Lnc-DCwas identified byWang et al.
in human conventional dendritic cells. Knockdown of lnc-DC
results in a failure of monocytes to differentiate into conventional
dendritic cells as well as affecting the ability of the cells to activate
T cells (13). HOTAIRM1 can regulate retinoic acid-mediated
granulocytic differentiation (14). More recently, lnc-MC has been
shown to be required formacrophage differentiation (15). It acts as
a competitive endogenous RNA sequestering miR-199a-5p from
its protein target activin A receptor type 1B that is a critical
regulator of monocyte/macrophage differentiation.
EXTRACELLULAR RNA
The study of extracellular RNA has intensified over recent
years. Much interest is focused on trying to understand how
these exRNAs can communicate and travel between cells, the
impact they have as well as their possible use as easily acces-
sible biomarkers for disease. The major species of RNA found
within extracellular vesicles (EVs) are small RNA including
miRNA. Recent evidence suggest that miR21 can be released
from tumor cells within EVs and where it can act as a lig-
and for TLR7 and TLR8 in mice (16). A number of mRNA
as well as lncRNA have also been identified within EVs. This
topic is covered in depth by Van der Grein et al. (16). Intrigu-
ingly, there appears to be cell type specify in terms of the RNAs
exported into EVs; however, the full extent of their impact on
neighboring as well as far away cells has not been fully exam-
ined in vivo. Like all aspects of the immune response, this
process can be hijacked by microbial pathogens for their own
survival. Many viruses and bacteria have been shown to pack-
age RNAs into EVs, which are released into uninfected cells
where they can contribute to immune evasion. Further work
needed on extracellular RNAs how they impact immune signal-
ing; can their presence be harnessed therapeutically? Can we
design methods to easily detect these non-coding RNAs as diag-
nostic markers and could they represent targets for therapeutic
intervention?
CONCLUSION
Unlike the miRNA field our understanding of the molecular
mechanisms employed by lncRNA are at a very early stage. LncR-
NAs can originate from intergenic regions between two protein
coding genes, from divergent bi-directional promoters, which is
the focus of a number of papers covered in this research topic
(8, 9). LncRNA can overlap protein-coding genes and even arise
from transcription of enhancer regions (eRNAs) (17). LncRNA
can positively and negatively influence expression patterns of
other genes both in cis and in trans through binding chromatin-
modifying complexes (18). As the number of lncRNAs contin-
ues to rise so does the complexity of their functions. It is an
exciting time for the non-coding RNA field and this special
topic highlights many interesting aspects of non-coding RNA
function within the immune system. What is clear that is more
work is needed to understand the full extent to which these
genes contribute to key biological processes as well as disease
states.
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